We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
401
Argentiere Capital
Switzerland
– -$13.6M -116,152 Closed
NFA
402
Nationwide Fund Advisors
Ohio
– -$13.2M -112,986 Closed
MWNA
403
Marshall Wace North America
New York
– -$3.74M -31,964 Closed
BPM
404
Bowling Portfolio Management
Ohio
– -$3.06M -26,117 Closed
SCA
405
Secor Capital Advisors
New York
– -$3M -25,640 Closed
SCM
406
Sterling Capital Management
North Carolina
– -$2.17M -18,534 Closed
Credit Agricole
407
Credit Agricole
France
– -$1.67M -14,276 Closed
VF
408
Virtu Financial
New York
– -$1.28M -10,914 Closed
UCFA
409
United Capital Financial Advisors
Texas
– -$901K -7,691 Closed
CG
410
Clinton Group
New York
– -$768K -6,553 Closed
Capstone Investment Advisors
411
Capstone Investment Advisors
New York
– -$679K -5,799 Closed
TI
412
Trexquant Investment
Connecticut
– -$479K -4,086 Closed
TAF
413
Tredje AP-fonden
Sweden
– -$476K -4,060 Closed
SIM
414
Spark Investment Management
New York
– -$457K -3,900 Closed
GIM
415
Greylin Investment Management
Virginia
– -$396K -3,375 Closed
Balyasny Asset Management
416
Balyasny Asset Management
Illinois
– -$375K -3,200 Closed
GCA
417
Gideon Capital Advisors
New York
– -$348K -2,972 Closed
Commonwealth Equity Services
418
Commonwealth Equity Services
Massachusetts
– -$300K -2,559 Closed
PCM
419
Prelude Capital Management
New York
– -$282K -2,406 Closed
YMRC
420
Yorktown Management & Research Company
Virginia
– -$281K -2,400 Closed
QT
421
Quantbot Technologies
New York
– -$114K -975 Closed
NIMI
422
Natixis Investment Managers International
France
– -$86K -734 Closed
EWM
423
Evercore Wealth Management
New York
– -$59K -500 Closed
IR
424
Invictus RG
Bermuda
– -$49K -417 Closed
Bessemer Group
425
Bessemer Group
New Jersey
– -$16K -135 Closed
14 15 16
17
18

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.